Reuters - An experimental drug being developed by Roche Holding AG removed amyloid plaques from the brains of Alzheimer's disease patients in a small early-stage study, according to data published in the Archives of Neurology, the Swiss drugmaker said on Monday.
Source: http://us.rd.yahoo.com/dailynews/rss/seniors/*http://news.yahoo.com/s/nm/20111010/hl_nm/us_roche_alzheimers
Allysin Chaynes almanacs alphabet altavista alternative alternative health
No comments:
Post a Comment